1
Stanley M Crain, Ke Fei Shen: Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opiod agonists. Albert Einstein College of Medicine of Yeshiva University a Division of Yeshiva University, Amster Rothstein & Ebenstein, April 30, 1996: US05512578 (102 worldwide citation)

This invention relates to a method of selectively enhancing the analgesic potency of morphine and other clinically used bimodally-acting opioid agonists and simultaneously attenuating development of physical dependence, tolerance and other undesirable side effects caused by the chronic administratio ...


2
Stanley M Crain, Ke fei Shen: Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists. Albert Einstein College of Medicine of Yeshiva University a Division of Yeshiva University, Amster Rothstein & Ebenstein, December 3, 1996: US05580876 (96 worldwide citation)

This invention relates to a method for selectively enhancing the analgesic potency of a bimodally-acting opioid agonist such as morphine and simultaneously attenuating anti-analgesia, hyperalgesia, hyperexcitability, physical dependence and/or tolerance effects associated with the administration of ...


3
Stanley M Crain, Ke fei Shen: Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists. Albert Einstein College of Medicine of Yeshiva University a Division of Yeshiva University, Amster Rothstein & Ebenstein, June 16, 1998: US05767125 (92 worldwide citation)

This invention relates to a method for selectively enhancing the analgesic potency of a bimodally-acting opioid agonist such as morphine and simultaneously attenuating anti-analgesia, hyperalgesia, hyperexcitability, physical dependence and/or tolerance effects associated with the administration of ...


4
Stanley M Crain, Ke fei Shen, John A Kessler, Stuart C Apfel: Use of excitatory opioid receptor antagonists to prevent growth factor-induced hyperalgesia. Albert Einstein College of Medicine of Yeshiva University a Division of Yeshiva University, Amster Rothstein & Ebenstein, December 17, 1996: US05585348 (84 worldwide citation)

This invention relates to a method of preventing hyperalgesia and other undesirable side-effects associated with the administration of growth factor, including nerve growth factor, utilizing an antagonist capable of inactivating excitatory opioid receptor-mediated functions on neurons in the nocicep ...


5
Philippe Leboulch, Eric Bouhassira, Karen Westerman, Ken Julian Takekoshi: Methods and compositions for transforming cells. Albert Einstein College of Medicine of Yeshiva University a Division of Yeshiva University, Massachusetts Institute of Technology, Jane E Remillard Esq, Lahive & Cockfield, July 27, 1999: US05928914 (50 worldwide citation)

Methods and compositions for transforming cells, resulting in efficient and stable site-specific integration of transgenes, are disclosed. Transformation is achieved by introducing into a cell an acceptor vector, preferably a retroviral vector, which integrates into the genome of the cell. The accep ...


6

7
Lola C M Reid, Marcos Rojkind: Method for isolation of connective tissue biomatrix. Albert Einstein College of Medicine of Yeshiva University a division of Yeshiva University, February 10, 1987: US04642292 (40 worldwide citation)

A method is disclosed for isolation of connective tissue fibers, called biomatrix, containing a significant portion of the extracellular matrix, i.e., basement membrane components and components of the ground substance. The connective tissue fibers isolated by this method provide significantly highe ...


8
Andrew J Dannenberg, Jayanta R Chowdhury: Treatment of newborn jaundice. Cornell Research Foundation, Albert Einstein College of Medicine of Yeshiva University a Division of Yeshiva University, December 31, 1996: US05589504 (38 worldwide citation)

Based on the discovery that the human bilirubin/phenol UDP-glucuronosyltransferase ugt1 gene complex contains an electrophile responsive element and the knowledge that the rat NADP(H):quinone reductase gene contains an electrophile responsive element, agents which at a concentration of less than 50 ...


9
Lola M Reid, Maria Agelli, Andreas Ochs: Method of expanding hepatic precursor cells. Albert Einstein College of Medicine of Yeshiva University a Division of Yeshiva University, Amster Rothstein & Ebenstein, November 19, 1996: US05576207 (32 worldwide citation)

A composition which comprises an animal cell population, and which contains immature animal cells. The immature animal cells are characterized by expression of alpha-fetoprotein or lack of essential expression of alpha-fetoprotein and albumin, and at least a portion of said immature animal cells or ...


10
William R Jacobs, Graham F Hatfull: D29 shuttle phasmids and uses thereof. Albert Einstein College of Medicine of Yeshiva University a Division of Yeshiva University, University of Pittsburgh, Amster Rothstein & Ebenstein, June 30, 1998: US05773267 (30 worldwide citation)

The present invention provides a conditional shuttle phasmid constructed by inserting a cosmid into a non-essential region of the D29 mycobacteriophage which is capable of introducing DNA of interest into the chromosome of mycobacteria, especially M. tuberculosis complex organisms and other slow gro ...